Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

Ilya Kister, Tim Spelman, Raed Alroughani, Jeannette Lechner-Scott, Pierre Duquette, Francois Grand'Maison, Mark Slee, Alessandra Lugaresi, Michael Barnett, Pierre Grammond, Gerardo Iuliano, Raymond Hupperts, Eugenio Pucci, Maria Trojano, Helmut Butzkueven

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)1133-1137
JournalJournal of Neurology Neurosurgery and Psychiatry
Volume87
Issue number10
DOIs
Publication statusPublished - Oct 2016

Cite this

Kister, I., Spelman, T., Alroughani, R., Lechner-Scott, J., Duquette, P., Grand'Maison, F., Slee, M., Lugaresi, A., Barnett, M., Grammond, P., Iuliano, G., Hupperts, R., Pucci, E., Trojano, M., & Butzkueven, H. (2016). Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study. Journal of Neurology Neurosurgery and Psychiatry, 87(10), 1133-1137. https://doi.org/10.1136/jnnp-2016-313760